088350.KS
Hanwha Life Insurance Co., Ltd. [088350.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
088350.KS Stock Summary
Top 088350.KS Correlated Resources
088350.KS
Top 10 Correlated ETFs
088350.KS
Top 10 Correlated Stocks
088350.KS
088350.KS Financial details
Company Rating
Buy
Market Cap
1855.93B
Income
1071.84B
Revenue
16253.67B
Book val./share
7763.05
Cash/share
-
Dividend
-
Dividend %
-
Employees
2.49K
Optionable
No
Shortable
Yes
Earnings
07 Feb 2023
P/E
1.83
Forward P/E
-
PEG
0.03
P/S
0.12
P/B
0.31
P/C
-
P/FCF
1.35
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.28K
EPS next Y
-
EPS next Q
-
EPS this Y
690.76%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
13.96%
Revenue last 5Y
-0.02%
Revenue Q/Q
-
EPS Q/Q
24.6%
-
-
-
-
SMA20
12.51%
SMA50
6.07%
SMA100
13.83%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
12%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
7%
Payout
-
Shs Outstand
751.39M
Shs Float
291.02M
-
-
-
-
Target Price
-
52W Range
1895.0-3420.0
52W High
-29.53%
52W Low
+27.18%
RSI
56
Rel Volume
0.97
Avg Volume
1.48M
Volume
1.44M
Perf Week
-0.62%
Perf Month
10.8%
Perf Quarter
1.26%
Perf Half Y
-4.55%
-
-
-
-
Beta
1.3182
-
-
Volatility
49.05%, 114.03%
Prev Close
1.9%
Price
2410
Change
0%
088350.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 28.15K | 28.62K | 25.28K | 26.78K | 28.07K | |
| Net income per share | 778.48 | 552.67 | 133.65 | 312.6 | 1.58K | |
| Operating cash flow per share | 4.42K | 2.19K | 1.34K | 2.01K | 7.39K | |
| Free cash flow per share | 4.23K | 1.92K | 1.14K | 1.79K | 7.24K | |
| Cash per share | 1.63K | 48.45K | 106.15K | 109.25K | 124.53K | |
| Book value per share | 12.45K | 13.72K | 16.88K | 16.84K | 14.98K | |
| Tangible book value per share | 11.87K | 13.59K | 17.08K | 17.03K | 16.28K | |
| Share holders equity per share | 12.45K | 13.72K | 16.88K | 16.84K | 14.98K | |
| Interest debt per share | 455.02 | 918.72 | 739.94 | 734.77 | 9.28K | |
| Market cap | 5432.55B | 3234.74B | 1562.89B | 2007.88B | 2213B | |
| Enterprise value | 4551.84B | 1294.17B | 148.48B | 1002.18B | 6601.08B | |
| P/E ratio | 9.29 | 7.79 | 15.56 | 8.54 | 1.86 | |
| Price to sales ratio | 0.26 | 0.15 | 0.08 | 0.1 | 0.1 | |
| POCF ratio | 1.64 | 1.97 | 1.55 | 1.33 | 0.4 | |
| PFCF ratio | 1.71 | 2.24 | 1.83 | 1.49 | 0.41 | |
| P/B Ratio | 0.58 | 0.31 | 0.12 | 0.16 | 0.2 | |
| PTB ratio | 0.58 | 0.31 | 0.12 | 0.16 | 0.2 | |
| EV to sales | 0.22 | 0.06 | 0.01 | 0.05 | 0.31 | |
| Enterprise value over EBITDA | 4.14 | 1.55 | 0.43 | 1.69 | 3.52 | |
| EV to operating cash flow | 1.37 | 0.79 | 0.15 | 0.66 | 1.19 | |
| EV to free cash flow | 1.43 | 0.9 | 0.17 | 0.74 | 1.21 | |
| Earnings yield | 0.11 | 0.13 | 0.06 | 0.12 | 0.54 | |
| Free cash flow yield | 0.59 | 0.45 | 0.55 | 0.67 | 2.46 | |
| Debt to equity | 0.04 | 0.07 | 0.04 | 0.04 | 0.62 | |
| Debt to assets | 0.92 | 0.91 | 0.9 | 0.91 | 0.92 | |
| Net debt to EBITDA | -0.8 | -2.32 | -4.05 | -1.7 | 2.34 | |
| Current ratio | 0 | 0 | 0 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 5.67 | 3.96 | 10.03 | 6.44 | 4.67 | |
| Dividend Yield | 0.01 | 0.05 | 0.1 | 0.06 | 0.05 | |
| Payout ratio | 0.12 | 0.37 | 1.56 | 0.53 | 0.1 | |
| Sales general and administrative to revenue | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | -0.04 | -0.12 | -0.15 | -0.11 | -0.02 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -0.59 | -0.85 | -0.56 | -0.57 | -0.4 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 14.76K | 13.06K | 7.13K | 10.88K | 23.09K | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0.01 | |
| Graham Net | -152.43K | -112.13K | -64.01K | -70.04K | -74.97K | |
| Working capital | 0 | 0 | 0 | 0 | 0 | |
| Tangible asset value | 8917.06B | 10213.28B | 12830.72B | 12810.15B | 12257.79B | |
| Net current asset value | 0 | 0 | 0 | 0 | 0 | |
| Invested capital | 0.04 | 0.07 | 0.04 | 0.04 | 0.62 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 388.82B | 499.77B | 370.05B | 395.34B | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.06 | 0.04 | 0.01 | 0.02 | 0.11 | |
| Capex per share | -186.05 | -262.58 | -204.04 | -221.02 | -144.76 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 6.74K | 6.23K | 6.13K | 6.63K | 0 | |
| Net income per share | 422 | 428.92 | 45.11 | 359 | 447.31 | |
| Operating cash flow per share | 2.11K | 1.86K | -817.33 | 1.29K | -547.26 | |
| Free cash flow per share | 2.14K | 1.82K | -837.5 | 1.29K | -564.2 | |
| Cash per share | 114.03K | 106.65K | 70.49K | 73.89K | 0 | |
| Book value per share | 13.84K | 12.83K | 11.05K | 9.09K | 7.76K | |
| Tangible book value per share | 14.98K | 13.95K | 11.82K | 9.54K | 9.5K | |
| Share holders equity per share | 13.84K | 12.83K | 11.05K | 9.09K | 7.76K | |
| Interest debt per share | 8.85K | 7.95K | 9.56K | 10.55K | 0 | |
| Market cap | 2933.24B | 2579.62B | 2768.58B | 1808.03B | 1698.33B | |
| Enterprise value | 7712.14B | 6967.7B | 8773.78B | 7529.29B | 1698.33B | |
| P/E ratio | 2.14 | 1.71 | 17.46 | 1.55 | 1.17 | |
| Price to sales ratio | 0.54 | 0.47 | 0.51 | 0.34 | 0 | |
| POCF ratio | 1.71 | 1.58 | -3.85 | 1.72 | -3.82 | |
| PFCF ratio | 1.68 | 1.62 | -3.76 | 1.73 | -3.7 | |
| P/B Ratio | 0.26 | 0.23 | 0.28 | 0.24 | 0.27 | |
| PTB ratio | 0.26 | 0.23 | 0.28 | 0.24 | 0.27 | |
| EV to sales | 1.41 | 1.27 | 1.63 | 1.4 | 0 | |
| Enterprise value over EBITDA | 12.7 | 14.73 | 57.76 | 15.17 | 0 | |
| EV to operating cash flow | 4.51 | 4.26 | -12.21 | 7.18 | -3.82 | |
| EV to free cash flow | 4.43 | 4.37 | -11.92 | 7.18 | -3.7 | |
| Earnings yield | 0.12 | 0.15 | 0.01 | 0.16 | 0.21 | |
| Free cash flow yield | 0.59 | 0.62 | -0.27 | 0.58 | -0.27 | |
| Debt to equity | 0.64 | 0.62 | 0.87 | 1.16 | 0 | |
| Debt to assets | 0.92 | 0.92 | 0.93 | 0.94 | 0.95 | |
| Net debt to EBITDA | 7.87 | 9.28 | 39.53 | 11.53 | 0 | |
| Current ratio | 0 | 0 | 0 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 4.99 | 4.34 | -18.12 | 3.59 | -1.22 | |
| Dividend Yield | 0 | 0.01 | 0 | 0.02 | 0.01 | |
| Payout ratio | 0.03 | 0.1 | 0.26 | 0.14 | 0.03 | |
| Sales general and administrative to revenue | 0.02 | 0.01 | 0.03 | 0.03 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Capex to operating cash flow | 0 | -0.03 | 0.02 | 0 | 0.03 | |
| Capex to revenue | 0 | -0.01 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | -0.61 | -0.24 | -0.01 | -0.18 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 11.47K | 11.13K | 3.35K | 8.57K | 8.84K | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | -68.47K | -64.21K | -101.02K | -112.84K | -190.24K | |
| Working capital | 0 | 0 | 0 | 0 | 0 | |
| Tangible asset value | 12169.45B | 12257.79B | 10392.2B | 7748.97B | 0 | |
| Net current asset value | 0 | 0 | 0 | 0 | 0 | |
| Invested capital | 0.64 | 0.62 | 0.87 | 1.16 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 506.62B | 496.46B | 560.98B | 572.29B | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.03 | 0.03 | 0 | 0.04 | 0.06 | |
| Capex per share | 0 | -47.93 | -20.17 | -0.52 | -16.94 |
088350.KS Frequently Asked Questions
What is Hanwha Life Insurance Co., Ltd. stock symbol ?
Hanwha Life Insurance Co., Ltd. is a US stock and trading under the symbol 088350.KS
What is Hanwha Life Insurance Co., Ltd. stock quote today ?
Hanwha Life Insurance Co., Ltd. stock price is $2410 today.
Is Hanwha Life Insurance Co., Ltd. stock public?
Yes, Hanwha Life Insurance Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 1.48M
- Market Capitalization 1855.93B
- Employee 2.49K
- Headquarters Seoul,US
- IPO Date 2010-03-17
-
Website
https://www.hanwhalife.com 
Hanwha Life Insurance Co., Ltd. provides various insurance products to individual and corporate customers in South Korea, Vietnam, China, Indonesia, and internationally. The company offers health, retirement, investment, group, accident, and savings insurance products; retirement pension plans; consulting services; and asset management products. It offers its products through financial planner, group financial planner, general agency, and bancassurance, as well as through online. The company was formerly known as Korea Life Insurance Co., Ltd. and changed its name to Hanwha Life Insurance Co., Ltd. in October 2012. Hanwha Life Insurance Co., Ltd. was founded in 1946 and is headquartered in Seoul, South Korea.
